Rankings
▼
Calendar
IMA Q4 2019 Earnings — ImageneBio Inc Revenue & Financial Results | Market Cap Arena
IMA
ImageneBio Inc
$69M
Q4 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$3M
Gross Profit
-$3M
-112.7% margin
Operating Income
-$5M
-194.1% margin
Net Income
-$5M
-182.2% margin
EPS (Diluted)
$-0.20
Cash Flow
Operating Cash Flow
-$8M
Free Cash Flow
-$8M
Stock-Based Comp.
$360,000
Balance Sheet
Total Assets
$86M
Total Liabilities
$147M
Stockholders' Equity
-$61M
Cash & Equivalents
$82M
← FY 2019
All Quarters
Q1 2020 →
